Kentucky Trust Company’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Sell
15,411
-292
-2% -$23.6K 0.58% 50
2026
Q1
$1.36M Sell
15,703
-204
-1% -$19.5K 0.71% 46
2025
Q4
$1.53M Sell
15,907
-211
-1% -$20.5K 0.81% 42
2025
Q3
$1.54M Buy
16,118
+50
+0.3% +$4.6K 0.83% 38
2025
Q2
$1.4M Sell
16,068
-710
-4% -$60.2K 0.8% 39
2025
Q1
$1.51M Sell
16,778
-270
-2% -$24.2K 0.9% 38
2024
Q4
$1.36M Buy
+17,048
New +$1.48M 0.8% 38

Other funds holding MDT

Kentucky Trust Company's MDT Position: Q2 2026 in Review

Kentucky Trust Company reduced its Medtronic (MDT) stake by 1.9% in Q2 2026, selling an estimated $23.6K and leaving 15,411 shares worth $1.21M. The position accounts for 0.58% of the portfolio, ranked #50.

Kentucky Trust Company first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.54M in Q3 2025. 673 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Kentucky Trust Company held 15,411 shares of Medtronic worth $1.21M as of Q2 2026.
  • Kentucky Trust Company sold 292 Medtronic shares in Q2 2026, an estimated $23.6K.
  • Medtronic made up 0.58% of Kentucky Trust Company's portfolio in Q2 2026, its #50 holding.
  • Kentucky Trust Company first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • Kentucky Trust Company's Medtronic position peaked at $1.54M in Q3 2025.
  • 673 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Kentucky Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.